TRCT
SQZ

Tower Research Capital (TRC)’s SQZ Biotechnologies Company SQZ Stock Holding History

Tower Research Capital (TRC)’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,368
Closed -$1.72K – 6497
2023
Q2 		$1.72K Sell
6,368
-246
-4% -$140 ﹤0.01% 5331
2023
Q1 		$4K Sell
6,614
-3,660
-36% -$2.7K ﹤0.01% 5150
2022
Q4 		$7K Sell
10,274
-287
-3% -$627 ﹤0.01% 4658
2022
Q3 		$24K Buy
+10,561
New +$31.7K ﹤0.01% 3799
2022
Q2 		– Sell
-2,254
Closed -$11K – 6807
2022
Q1 		$11K Buy
2,254
+916
+68% +$5.82K ﹤0.01% 4245
2021
Q4 		$12K Buy
1,338
+787
+143% +$9.65K ﹤0.01% 4358
2021
Q3 		$8K Sell
551
-15,276
-97% -$207K ﹤0.01% 4591
2021
Q2 		$228K Buy
15,827
+13,815
+687% +$180K 0.01% 1822
2021
Q1 		$28K Buy
2,012
+1,580
+366% +$32.1K ﹤0.01% 3627
2020
Q4 		$13K Buy
+432
New +$11K ﹤0.01% 4175

Other funds holding SQZ

AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
BSB
Bangor Savings Bank Bangor, Maine $1.36B AUM 19.29% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Tower Research Capital (TRC)'s SQZ Position: Q3 2023 in Review

Tower Research Capital (TRC) sold out of SQZ Biotechnologies Company (SQZ) in Q3 2023, closing a stake of 6,368 shares — an estimated $1.72K sold.

Tower Research Capital (TRC) first reported a position in SQZ in Q4 2020 and held it in 10 quarters. The position peaked at $228K in Q2 2021. 5 funds tracked by Wall St. Rank hold SQZ as of Q3 2023.

  • Tower Research Capital (TRC) reported no remaining SQZ Biotechnologies Company position as of Q3 2023 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 6,368 SQZ Biotechnologies Company shares in Q3 2023, an estimated $1.72K.
  • Tower Research Capital (TRC) first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s SQZ Biotechnologies Company position peaked at $228K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q3 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2023, filed 14 Nov 2023.